• Users Online: 302
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Browse Articles Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Silymarin for the prevention of contrast-induced nephropathy: A placebo-controlled clinical trial

Sedighifard Zohreh, Roghani Farshad, Bidram Peyman, Harandi Samaneh Aalami, Molavi Safieh

Year : 2016| Volume: 7| Issue : 1 | Page no: 23-23

   This article has been cited by
 
1 Potential renoprotective effects of silymarin against vancomycin-induced nephrotoxicity in rats
Sevda Guzel,Zuhal Uckun Sahinogullari,Necmiye Canacankatan,Serife Efsun Antmen,Deniz Kibar,Banu Coskun Yilmaz
Drug and Chemical Toxicology. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Silymarin protects against radiocontrast-induced nephropathy in mice
Verônica de Souza Santos,Beatriz Peters,Larissa Zambom Côco,Gisele Maziero Alves,Arícia Leone Evangelista Monteiro de Assis,Breno Valentim Nogueira,Silvana Santos Meyrelles,Marcella Leite Porto,Elisardo Corral Vasquez,Bianca Prandi Campagnaro,Thiago Melo Costa Pereira
Life Sciences. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis
Khalid Ahmed,Terri McVeigh,Raminta Cerneviciute,Sara Mohamed,Mohammad Tubassam,Mohammad Karim,Stewart Walsh
BMC Nephrology. 2018; 19(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article